Muscle oxidative capacity during IL-6-dependent cancer cachexia. - Wikidata - wikimedia - TriplyDB

Muscle oxidative capacity during IL-6-dependent cancer cachexia.

Muscle oxidative capacity during IL-6-dependent cancer cachexia.

http://www.wikidata.org/entity/Q34598672

about

The Janus-Faced Role of Antioxidants in Cancer Cachexia: New Insights on the Established Concepts Mechanisms of metabolic dysfunction in cancer-associated cachexia Effects of sex steroids on bones and muscles: Similarities, parallels, and putative interactions in health and disease Quercetin supplementation attenuates the progression of cancer cachexia in ApcMin/+ mice.Cachectic skeletal muscle response to a novel bout of low-frequency stimulation Inhibition of Janus kinase signaling during controlled mechanical ventilation prevents ventilation-induced diaphragm dysfunction Sildenafil increases muscle protein synthesis and reduces muscle fatigue.The effect of radiation dose on mouse skeletal muscle remodeling.The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse.Increase in muscle mitochondrial biogenesis does not prevent muscle loss but increased tumor size in a mouse model of acute cancer-induced cachexia Interleukin 6 as a key regulator of muscle mass during cachexia Liver inflammation and metabolic signaling in ApcMin/+ mice: the role of cachexia progression.Sex differences in the relationship of IL-6 signaling to cancer cachexia progression Preserved muscle oxidative metabolic phenotype in newly diagnosed non-small cell lung cancer cachexia.The effect of exercise on IL-6-induced cachexia in the Apc ( Min/+) mouse.Mitochondrial dynamics in cancer and neurodegenerative and neuroinflammatory diseases.IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse.Eccentric contraction-induced myofiber growth in tumor-bearing mice.Testosterone regulation of Akt/mTORC1/FoxO3a signaling in skeletal muscle.Development of an UPLC mass spectrometry method for measurement of myofibrillar protein synthesis: application to analysis of murine muscles during cancer cachexia Molecular mechanisms underlying skeletal muscle weakness in human cancer: reduced myosin-actin cross-bridge formation and kinetics.The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting Pseudouridine synthase 1 deficient mice, a model for Mitochondrial Myopathy with Sideroblastic Anemia, exhibit muscle morphology and physiology alterations.TWEAK promotes exercise intolerance by decreasing skeletal muscle oxidative phosphorylation capacity.Characterization of the male ApcMin/+ mouse as a hypogonadism model related to cancer cachexia.Mitofusin-2 prevents skeletal muscle wasting in cancer cachexia.Short-term pyrrolidine dithiocarbamate administration attenuates cachexia-induced alterations to muscle and liver in ApcMin/+ mice.Candidate mechanisms underlying effects of contractile activity on muscle morphology and energetics in cancer cachexia.Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies.Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.Mitochondrial Dynamics: In Cell Reprogramming as It Is in Cancer.Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation.Altered cardiac muscle mTOR regulation during the progression of cancer cachexia in the ApcMin/+ mouse.Are there any benefits of exercise training in cancer cachexia?Cancer cachexia is associated with a decrease in skeletal muscle mitochondrial oxidative capacities without alteration of ATP production efficiency.Effect of colon cancer and surgical resection on skeletal muscle mitochondrial enzyme activity in colon cancer patients: a pilot study.Inflammatory signalling regulates eccentric contraction-induced protein synthesis in cachectic skeletal muscle.Skeletal Muscle Function During the Progression of Cancer Cachexia in the Male ApcMin/+ Mouse.Linking Cancer Cachexia-Induced Anabolic Resistance to Skeletal Muscle Oxidative Metabolism.Autophagy activation, not peroxisome proliferator-activated receptor γ coactivator 1α, may mediate exercise-induced improvements in glucose handling during diet-induced obesity.

P2860

Q28078802-03164838-487E-4027-A04D-EDE24237D99A Q28079213-A0DBFC32-FC3C-4599-B73E-CA03C29B04E5 Q28606560-1AF9CC03-C51B-4FAC-A08E-911C937D8D02 Q33602156-3FC38B44-CDFB-4F39-B45B-CC2AD7A6D782 Q33673314-6CF17E25-13A7-46F6-B910-EB86B3A6F2A8 Q33775184-25C7DAA6-8673-4845-B9C6-579C326E5449 Q33827719-93137176-6931-4372-AF89-7F2889AFEB65 Q33946332-9665D349-3C04-46AA-935A-04074DB5F521 Q34031423-50306645-396B-41E4-9EB2-29F5C1F69C7F Q34200939-79CC7EF9-44F3-4FFE-AEB8-6970CB1C046C Q34727530-A3CE3517-BF67-44AB-8E3C-08F139DC3954 Q35196068-334B4671-D7E9-4947-8D4B-F3905187FEC9 Q35214154-C18188CE-9A84-45C2-B1D0-C6F07CAAF8A9 Q35690207-BF97CB16-04ED-43E2-9CB4-85D17FDF25ED Q36028206-92D531F7-FAC4-4231-B1D8-748DFA5D9D5F Q36082495-5560213A-526C-40B9-8CD2-6E203E168D80 Q36200582-3464658C-C304-461C-8616-BBF21AC3ACBE Q36422662-CC7CF6B8-F161-4FC8-A377-6C401C0E7076 Q36487406-56D506ED-E092-4BC5-917B-9D52CF7DC98C Q36737744-FA7F7FF8-128E-4CC9-AFFB-57C2D8B39B6C Q36787452-A2D355D8-8369-4B51-B4A7-370098613445 Q36901945-9362DCC8-DADF-4E6A-8271-00F62E254A15 Q36919088-2433D87C-EE4F-4FB0-9667-E0D3DC590A0E Q37014194-7B2C4F4E-CF5C-47E5-B9FE-CE7CEE62D0F1 Q37392800-95AA8930-78AD-44EF-8CCA-469FB06646B2 Q37407291-8CF4524A-E2FA-4854-B196-75E70640BBC2 Q37644886-22A032EF-7629-431F-A44E-550EDC46C4BA Q37924325-E8BD6F54-3F34-448A-9817-4B6BE2195AB7 Q38090981-1F6590AA-84FB-4167-A8B6-E21D452F6C72 Q38606110-F7ECCBB5-7934-46F0-AD4C-C6471F5F20DC Q39292567-C30DE1F3-B626-464F-B93F-D36B51D70B29 Q41146515-07A1E721-F3E5-4B5E-8A7B-173463136C3C Q41293262-19DAA3D7-9380-4A50-B0BF-EDB987C34D6D Q42199742-F0D846EB-0A8E-45ED-8BCA-5EA667159D74 Q42350705-7AC5A289-A746-40AB-8732-4E170796D991 Q43240375-D647308D-B41B-4C84-945B-B4AE2308B5CE Q47320394-39F0D80B-59F5-48DB-AAC2-D5A4A578EA91 Q47419257-930A1A6E-91E9-49BB-AB5D-CE168F55DF7F Q48155681-36ED50D8-9151-4D48-A441-4C17233F1323 Q48238486-FDBE7FEA-3DB0-4A61-A588-8C51DFC6D59A

P2860

Muscle oxidative capacity during IL-6-dependent cancer cachexia.

http://www.wikidata.org/entity/Q34598672

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Muscle oxidative capacity during IL-6-dependent cancer cachexia.

@ast

Muscle oxidative capacity during IL-6-dependent cancer cachexia.

@en

Muscle oxidative capacity during IL-6-dependent cancer cachexia.

@nl

type

label

Muscle oxidative capacity during IL-6-dependent cancer cachexia.

@ast

Muscle oxidative capacity during IL-6-dependent cancer cachexia.

@en

Muscle oxidative capacity during IL-6-dependent cancer cachexia.

@nl

prefLabel

Muscle oxidative capacity during IL-6-dependent cancer cachexia.

@ast

Muscle oxidative capacity during IL-6-dependent cancer cachexia.

@en

Muscle oxidative capacity during IL-6-dependent cancer cachexia.

@nl

P1433

Q34598672-65E07AE3-82AB-4BD5-A602-59229C6CF0D7

P1476

Q34598672-556DC1F7-79C0-4EC4-B68E-5125D2653387

P2093

Q34598672-387AA7D1-F288-452F-84D7-473A3226D3DE

Q34598672-5FE3E55E-6001-416D-B144-67EB5071B513

Q34598672-6E29C4F6-36B7-4235-A7CE-4260D8FB8E02

Q34598672-92E24FD7-23A7-4B3A-9F0B-ED2A876E888B

Q34598672-C1A4007E-8F79-43C0-A504-DC7B5B00AA1E

P2860

Q34598672-03668075-5132-431B-B47F-BB0AEC2FCEE9

Q34598672-0486E5F7-7C02-4F71-A368-7E60A0B28CCE

Q34598672-05B7B506-C525-4978-8E4A-63BE73EEBAF1

Q34598672-05FDF7CF-FBB6-4962-9425-BF5260E35D2E

Q34598672-065F113C-75FF-4635-9683-C23667D29187

Q34598672-0F8D37EF-6414-40B6-A8B8-4546F3E61E9B

Q34598672-183F62DE-AEA1-4FE1-9C3D-B65D848156A3

Q34598672-1D774D19-D62F-43C7-8DC9-5C3AA769FE1E

Q34598672-2142C8FB-24A2-41B3-9451-A0617EC46B16

Q34598672-232BC783-A55C-43D4-805B-14BA62FA2AC6

P304

Q34598672-9FFE3539-43C3-4FBD-8775-0BB7CFD86CC3

P31

Q34598672-6CC4E203-FFEC-4231-98C6-05D265FB0DED

P356

Q34598672-7896327A-12A8-4ECA-9EFF-F2114BDDB5A4

P433

Q34598672-C9B3DDF9-982D-4DBE-9DA7-A3925AFE79C2

P478

Q34598672-7225DFF4-FB89-46DE-9BD5-7221D6AB6793

P50

Q34598672-5CF12E1A-2691-459D-A19C-F0C3F9BF299B

P577

Q34598672-9AAA07E6-4716-4D8E-A3F6-060E74AE677F

P5875

Q34598672-1D96B3C4-C608-48BF-8981-7F4306D06F73

P698

Q34598672-4FAFA077-5197-404C-B86D-EE5A4C163BB7

P932

Q34598672-A23F3CB8-D527-435F-B68E-A889F96C0788

P356

AJPREGU.00300.2010

P1433

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

P1476

Muscle oxidative capacity during IL-6-dependent cancer cachexia

@en

P2093

James P White

http://www.w3.org/2001/XMLSchema#string

John W Baynes

http://www.w3.org/2001/XMLSchema#string

Kristen A Baltgalvis

http://www.w3.org/2001/XMLSchema#string

Melissa J Puppa

http://www.w3.org/2001/XMLSchema#string

Shuichi Sato

http://www.w3.org/2001/XMLSchema#string

P2860

Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator

Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

hFis1, a novel component of the mammalian mitochondrial fission machinery

Interleukin-6 and cachexia in ApcMin/+ mice

Response of mitochondrial fusion and fission protein gene expression to exercise in rat skeletal muscle

Changes in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

P304

R201-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPREGU.00300.2010

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

300

http://www.w3.org/2001/XMLSchema#string

P50

James A. Carson

P577

2010-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49674341

http://www.w3.org/2001/XMLSchema#string

P698

21148472

http://www.w3.org/2001/XMLSchema#string

P932

3043802

http://www.w3.org/2001/XMLSchema#string